Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    23388004 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia)
Condition: Cutaneous Leishmaniasis
Interventions: Drug: WR 279,396 topical cream;   Drug: Paromomycin Alone topical cream;   Drug: Vehicle placebo cream
2 Not yet recruiting Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia
Conditions: Leishmaniasis, Cutaneous;   Leishmania Braziliensis Complex;   Leishmaniasis, American;   Leishmaniasis; American, Cutaneous
Interventions: Drug: Paromomycin Sulfate;   Drug: Pentamidine Isethionate;   Other: Placebo

Study has passed its completion date and status has not been verified in more than two years.